Tamiflu in 2009 and Remdesivir in 2019 and what will be the next wonder drug?

by | Jul 26, 2021 | Blog

What have we learned in ten years? I was a pharmacist in retail practice in 2009 and was a site that collected all the unused Tamiflu which ended up being destroyed having cost billions across the world. When medicines are hyped up on limited clinical evidence there is often a follow up by the regulators to limit the use to prevent patient harm. The pandemic panic, press, social media and drug companies have a part to play but even in a pandemic evidence-based medicine is a must and the public and health professionals deserve to be informed after a full independent review of clinical trials. If we are not careful pharma warehouses will be full of unwanted medicines as in 2009.

Testimonials

I attended one of the first virtual GDP Responsible Person Cogent “Gold Standard” training sessions due to the Covid-19 social distancing requirements. regardless of the circumstances the training was well organised and delivered to the required standard. This is why I recommended my associates to utilise PCL. Thank you Ryan, Sally, Adel and Jackie. Goncalo Sousa –  Quality Head UK at the Janssen Pharmaceutical Companies of Johnson & Johnson 05/05/2020
Cogent Gold Standard GDP Online Training